share_log

HC Wainwright & Co. Reiterates Buy on IO Biotech, Maintains $8 Price Target

Moomoo 24/7 ·  Mar 6 08:21

HC Wainwright & Co. analyst Emily Bodnar reiterates IO Biotech (NASDAQ:IOBT) with a Buy and maintains $8 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment